Esophageal Precancer Testing Program Launched at Hoag
Lucid Diagnostics and Hoag have launched a comprehensive esophageal precancer screening program using the non-endoscopic EsoGuard DNA test.
Lucid Diagnostics and Hoag have launched a comprehensive esophageal precancer screening program using the non-endoscopic EsoGuard DNA test.
Researchers diagnosed leptomeningeal disease in diffuse midline gliomas by detecting H3K27M-mutant ctDNA from cerebrospinal fluid.
Roche’s VENTANA CLDN18 RxDx Assay identifies CLDN18 protein expression in gastric and gastroesophageal junction cancer patients.
Cancer Check Labs has been chosen as the exclusive provider of early cancer detection tests for Ways2Well, a regenerative medicine clinic.
Read MoreResearchers are developing a mouthwash-based test to detect biomarkers that may help predict the recurrence of head and neck cancer.
Read MoreThermo Fisher’s SeCore CDx HLA A Sequencing System received FDA clearance as a CDx for TECELRA, a T-cell receptor therapy from Adaptimmune.
Read MoreA blood test measuring lymphocyte levels may predict the effectiveness of CAR-T immunotherapy in relapsed multiple myeloma patients.
Read MoreA new machine-learning serum fusion-gene model shows promise in increasing hepatocellular carcinoma diagnostic accuracy and monitoring.
Read MoreResearcher identified a 15-gene signature biomarker that can stratify renal cancer patients into low or high risk of recurrence.
Read MoreA new genotyping test using cerebrospinal fluid can rapidly diagnose brain cancers, reducing the need for invasive biopsies.
Read MoreResearchers discovered a novel immune-based biomarker that could pave the way for potential early detection of high-grade ovarian cancer.
Read MoreA clinical trial shows that a Helio Genomics test outperforms ultrasound in detecting hepatocellular carcinoma in liver cirrhosis patients.
Read MoreSalignostics has partnered with ARC Innovation at Sheba Medical Center to develop a saliva-based test for detecting oral cavity cancer.
Read MoreMercy BioAnalytics will present data showing that their Mercy Halo test significantly improves early detection of ovarian cancer.
Read MoreResearchers discovered new biomarkers for renal cell carcinomas, enhancing the diagnosis of various subtypes.
Read MoreThe tumor cell enumeration assay is a diagnostic test that is promising for establishing the diagnosis of leptomeningeal metastases.
Read MoreThe U.S. Patent and Trademark Office issued a patent to Myriad Genetics aimed at strengthening its ability to deliver a MRD assay to market.Â
Read MoreA new algorithm may help identify high-risk precancerous lesions on the fallopian tubes thought to lead to a common form of ovarian cancer
Read More